Globus Medical (GMED) Net Margin (2011 - 2026)

Globus Medical's Net Margin history runs 16 years deep, the most recent figure standing at 16.36% for Q1 2026.

• Quarterly Net Margin rose 374.0% year-over-year to 16.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.92% (up 1153.0% YoY) and the FY2025 annual result came in at 18.3%, up 1421.0% from the prior year.
• Net Margin was 16.36% for Q1 2026 at Globus Medical, down from 17.01% in the prior quarter.
• Across five years, Net Margin topped out at 27.22% in Q2 2025 and bottomed at 1.18% in Q1 2024.
• A 5-year average of 12.42% and a median of 15.47% in 2025 frame the typical range for Net Margin.
• Annual changes were most pronounced in 2022 — Net Margin surged 7798 bps — and 2024, when it sank 1894 bps.
• Globus Medical's Net Margin stood at 10.1% in 2022, then tumbled by 76 bps to 2.44% in 2023, then soared by 65 bps to 4.03% in 2024, then jumped by 322 bps to 17.01% in 2025, then slipped by 4 bps to 16.36% in 2026.
• Business Quant data shows GMED's Net Margin at 16.36% in Q1 2026, 17.01% in Q4 2025, and 15.47% in Q3 2025.